Perispinal Etanercept for Treatment of Alzheimers Disease
about
Rapid improvement in verbal fluency and aphasia following perispinal etanercept in Alzheimer's disease.Perispinal etanercept: potential as an Alzheimer therapeuticPerispinal etanercept produces rapid improvement in primary progressive aphasia: identification of a novel, rapidly reversible TNF-mediated pathophysiologic mechanismAlzheimer's Disease: Exploring the Role of Inflammation and Implications for TreatmentRapid cognitive improvement in Alzheimer's disease following perispinal etanercept administration.Rapid intracerebroventricular delivery of Cu-DOTA-etanercept after peripheral administration demonstrated by PET imaging.Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidenceThalidomide Analogues Suppress Lipopolysaccharide-Induced Synthesis of TNF-α and Nitrite, an Intermediate of Nitric Oxide, in a Cellular Model of InflammationTNF-α protein synthesis inhibitor restores neuronal function and reverses cognitive deficits induced by chronic neuroinflammation.Cognitive dysfunction with aging and the role of inflammationA cellular model of inflammation for identifying TNF-alpha synthesis inhibitors.Perispinal etanercept: a new therapeutic paradigm in neurology.Current therapies and new strategies for the management of Alzheimer's disease.The potential role of proinflammatory and antiinflammatory cytokines in Alzheimer disease pathogenesis.The role of glial cells and the complement system in retinal diseases and Alzheimer's disease: common neural degeneration mechanisms.Perispinal Delivery of CNS Drugs.Cytokines and Cytokine Receptors Involved in the Pathogenesis of Alzheimer's Disease.Is there a causal link between inflammation and dementia?The effect of chronic periodontitis on serum levels of tumor necrosis factor-alpha in Alzheimer disease.Selective TNF inhibition for chronic stroke and traumatic brain injury: an observational study involving 629 consecutive patients treated with perispinal etanercept.Authors' reply to Whitlock: Perispinal etanercept for post-stroke neurological and cognitive dysfunction: scientific rationale and current evidence.Rapid improvement of chronic stroke deficits after perispinal etanercept: three consecutive cases.Mechanisms of Risk Reduction in the Clinical Practice of Alzheimer's Disease Prevention.The Inflammatory Nature of Post-surgical Delirium Predicts Benefit of Agents With Anti-TNF Effects, Such as Dexmedetomidine.
P2860
Q21261380-2AAF66CD-2C78-47C8-B217-B6B999FB7560Q22241758-BF22E51F-B5C6-4352-A530-AD76DE310B6BQ24652684-EDB3E5A8-7814-4B1F-AD04-51EE66ADB1ABQ26776157-107D90CD-9AE1-43FB-B540-2E6916AD53F3Q30481096-8BFCE6E3-A5B9-4FE4-B26C-68C2FB49E5B8Q33417987-336CF226-EDC8-400B-B36D-ACC9195BDB35Q33947639-608A890B-D055-4F6A-85B0-084A8477A29DQ35121026-04066456-EA8D-45F7-8AE5-972F915CFA6CQ35818467-A9DE4301-E6D8-44F5-841E-0016A3E01043Q36443732-84C6656E-D1BD-4673-9AC4-C3B09D677373Q37375005-C010F840-8C1A-49A2-8139-246942C24B2AQ37762260-8313903D-7A77-4819-BB46-8399533AF22AQ37770005-353E2860-C66B-4836-8604-BBC67B96A408Q38042681-542F8BF1-CC53-447F-8EFA-07E49D3A2F82Q38245648-E35AE85B-A7FF-45B9-8CBE-6937CAB7A1FBQ38819013-A3335EAF-C4F5-4B49-9787-8E99D431D16EQ39023028-83591692-DC99-4F0F-B8E1-EC891E6F22EDQ39387457-56F5CDCA-584A-4DE6-8964-46F80456C98FQ42180608-B1EB1D2E-64E7-4D56-9E90-29C1803DCC0FQ42674268-AB51502E-F0DF-4636-89F0-64A2C9E61AFEQ43041358-B674FA48-9DC0-4EA6-9764-7C2A3599CC3AQ46473889-30FECFB1-BB7A-4FD7-B3FD-509A63E9D85BQ55090853-7E4B316D-A185-4C21-9468-7895D9061DBCQ55130777-8BD5F93A-7022-4394-A047-FABC55A7AB49
P2860
Perispinal Etanercept for Treatment of Alzheimers Disease
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Perispinal Etanercept for Treatment of Alzheimers Disease
@ast
Perispinal Etanercept for Treatment of Alzheimers Disease
@en
Perispinal Etanercept for Treatment of Alzheimers Disease
@en-gb
type
label
Perispinal Etanercept for Treatment of Alzheimers Disease
@ast
Perispinal Etanercept for Treatment of Alzheimers Disease
@en
Perispinal Etanercept for Treatment of Alzheimers Disease
@en-gb
prefLabel
Perispinal Etanercept for Treatment of Alzheimers Disease
@ast
Perispinal Etanercept for Treatment of Alzheimers Disease
@en
Perispinal Etanercept for Treatment of Alzheimers Disease
@en-gb
P3181
P1476
Perispinal Etanercept for Treatment of Alzheimers Disease
@en
P2093
Edward Tobinick
P304
P3181
P356
10.2174/156720507783018217
P577
2007-12-01T00:00:00Z